Description

Bravylol contains nebivolol, a selective β1-blocker, which reduces heart rate, blood pressure and peripheral systemic vascular resistance.

 

Indications

Bravylol is indicated for the treatment of:

  • essential hypertension;
  • stable mild and moderate chronic heart failure in addition to standard therapies in elderly patients (>70 years).

 

Subject to medical prescription.

 

Concentration and pharmaceutical form: 5 mg tablets

Category
Cardiovascular system